Tilray Brands, Inc. held its 2026 Annual Meeting of Stockholders on November 18, 2026, where significant proposals were put to a vote. The outcomes of this meeting are important for the company as they reflect shareholder confidence and influence future governance. Key proposals included the re-election of directors and the ratification of the company's accounting firm.
Tilray Brands, Inc. is classified under the SIC code 2833, which corresponds to Medicinal Chemicals & Botanical Products. The company operates on the Nasdaq exchange under the ticker TLRY. This sector is characterized by its focus on developing and distributing medicinal products derived from botanical sources.
According to the filing, the stockholders voted on three main proposals. The first was the election of David Clanachan, Renah Persofsky, and Irwin Simon as Class II directors, each serving until the 2029 Annual Meeting. The second proposal involved the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending May 31, 2027. The final proposal sought to amend the Company’s Amended and Restated Certificate of Incorporation to declassify the Board of Directors and allow stockholders to remove directors with or without cause.
All three director nominees were re-elected under the plurality voting standard. The appointment of PricewaterhouseCoopers LLP was ratified by a majority vote. However, the governance amendment did not pass, failing to receive the required two-thirds majority of outstanding shares.
The voting results for the proposals were as follows:
Proposal No. 1 – Re-Election of Class II Directors:
David Clanachan: 11,856,346 votes for, 5,650,082 against, 40,439,573 broker non-votes.
Renah Persofsky: 9,836,559 votes for, 7,669,869 against, 40,439,573 broker non-votes.
Irwin Simon: 10,584,464 votes for, 6,921,964 against, 40,439,573 broker non-votes.
Proposal No. 2 – Ratification of PWC:
For: 50,955,618 votes, Against: 5,525,439 votes, Abstain: 1,464,944 votes.
Proposal No. 3 – Governance Changes Proposal:
For: 13,519,077 votes, Against: 3,593,826 votes, Abstain: 393,525 votes, Broker Non-Votes: 40,439,573.
These results indicate a strong support for the re-elected directors and the accounting firm, while also highlighting shareholder hesitance regarding governance changes. This may signal a need for Tilray to engage further with its shareholders to address concerns regarding governance and decision-making processes.
Looking ahead, the filing does not specify what actions will follow this annual meeting. However, the outcomes may influence Tilray's strategies in governance and shareholder relations moving forward.
Read Next
Clark Kyle Sells 15,000 Shares of Beta Technologies Stock
Ronald R. Taylor resigns as director of ResMed Inc.
Afsari Nasym acquires 68,235 shares of Onterris, Inc.
Onterris, Inc. Chief Strategy Officer Acquires Shares
StubHub Holdings' Mark Streams Sells 76,891 Shares
Francesca M. Edwardson Transfers 25,000 Shares to Trust




